Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: Role of HMGB1-TLR4 signaling

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6573-6580

  Fan, Jie ^a,b   Li, Yuehua ^a   Levy, Ryan M ^a   Fan, Janet J ^c   Hackam, David J ^c   Vodovotz, Yoram ^a   Yang, Huan ^d   Tracey, Kevin J ^d   Billiar, Timothy R ^a   Wilson, Mark A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL STIMULATION; DRUG LIVER LEVEL; ENZYME ACTIVATION; HEMORRHAGIC SHOCK; IN VITRO STUDY; LUNG; MALE; MOUSE; MOUSE MUTANT; NEUTROPHIL; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RESUSCITATION; STATISTICAL SIGNIFICANCE; WILD TYPE;

EID: 34248228729     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6573     Document Type: Article

References (62)

1. Botha, A. J., F. A. Moore, E. E. Moore, F. J. Kim, A. Banerjee, and V. M. Peterson. 1995. Postinjury neutrophil priming and activation: an early vulnerable window. Surgery 118: 358-364.
2. Hogg, J. C. 1987. Neutrophil kinetics and lung injury. Physiol. Rev. 67: 1249-1295.
3. Fan, J., Y. Li, Y. Vodovotz, T. R. Billiar, and M. A. Wilson. 2006. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am. J. Physiol. 290: L738-L746.
4. Abdelrahman, M., E. Mazzon, M. Bauer, I. Bauer, S. Delbosc, J. P. Cristol, N. S. Patel, S. Cuzzocrea, and C. Thiemermann. 2005. Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock. Shock 23: 107-114.
5. Lehnen, M., G. E. Arteel, O. M. Smutney, L. O. Conzelmann, Z. Zhong, R. G. Thurman, and J. J. Lemasters. 2003. Dependence of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide. Shock 19: 345-351.
6. Akgur, F. M., M. F. Brown, G. B. Zibari, J. C. McDonald, C. J. Epstein, C. R. Ross, and D. N. Granger. 2000. Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am. J. Physiol. 279: H791-H797.
7. Lambeth, J. D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4: 181-189.
8. Groemping, Y., and K. Rittinger. 2005. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J. 386: 401-416.
9. phox by ERK2 and P38MAPK: selectivity of phosphorylated sites and existence of an intramolecular regulatory domain in the tetratricopeptide-rich region. Biochemistry 42: 4520-4526.
10. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305.
11. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
12. Termeer, C., F. Benedix, J. Sleeman, C. Fieber, U. Voith, T. Ahrens, K. Miyake, M. Freudenberg, C. Galanos, and J. C. Simon. 2002. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195: 99-111.
13. Johnson, G. B., G. J. Brunn, Y. Kodaira, and J. L. Platt. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168: 5233-5239.
14. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167: 2887-2894.
15. Tsung, A., R. Sahai, H. Tanaka, A. Nakao, M. P. Fink, M. T. Lotze, H. Yang, J. Li, K. J. Tracey, D. A. Geller, and T. R. Billiar. 2005. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201: 1135-1143.
16. Park, J. S., D. Svefkauskaite, Q. He, J. Y. Kim, D. Strassheim, A. Ishizaka, and E. Abraham. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279: 7370-7377.
17. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112.
18. Zhai, Y., X. D. Shen, R. O'Connell, F. Gao, C. Lassman, R. W. Busuttil, G. Cheng, and J. W. Kupiec-Weglinski. 2004. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J. Immunol. 173: 7115-7119.
19. Prince, J. M., R. M. Levy, R. Yang, K. P. Mollen, M. P. Fink, Y. Vodovotz, and T. R. Billiar. 2006. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J. Am. Coll. Surg. 202: 407-417.
20. Lotze, M. T., and K. J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5: 331-342.
21. Wang, H., O. Bloom, M. Zhang, J. M. Vishnubhakat, M. Ombrellino, J. Che, A. Frazier, H. Yang, S. Ivanova, L. Borovikova, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
22. Yang, H., M. Ochani, J. Li, X. Qiang, M. Tanovic, H. E. Harris, S. M. Susarla, L. Ulloa, H. Wang, R. DiRaimo, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101: 296-301.
23. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-478.
24. Zeh, H. J., III, and M. T. Lotze. 2005. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J. Immunother. 28: 1-9.
25. Kim, J. Y., J. S. Park, D. Strassheim, I. Douglas, F. Diaz Del Valle, K. Asehnoune, S. Mitra, S. H. Kwak, S. Yamada, I. Maruyama, et al. 2005. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am. J. Physiol. 288: L958-L965.
26. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
27. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189: 615-625.
28. Cotter, M. J., K. E. Norman, P. G. Hellewell, and V. C. Ridger. 2001. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am. J. Pathol. 159: 473-481.
29. Boiadjieva, S., C. Hallberg, M. Hogstrom, and C. Busch. 1984. Methods in laboratory investigation: exclusion of trypan blue from microcarriers by endothelial cells: an in vitro barrier function test. Lab. Invest. 50: 239-246.
30. Okuyama, M., M. Sakon, J. Kambayashi, T. Kawasaki, and M. Monden. 1996. Involvement of protein phosphatase 2A in PKC-independent pathway of neutrophil superoxide generation by fMLP. J. Cell. Biochem. 60: 279-288.
31. Jin, D. Y., F. Spencer, and K. T. Jeang. 1998. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell 93: 81-91.
32. Kawabata, M., H. Inoue, A. Hanyu, T. Imamura, and K. Miyazono. 1998. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17: 4056-4065.
33. Fleming, I. N., C. M. Elliott, J. G. Collard, and J. H. Exton. 1997. Lysophosphatidic acid induces threonine phosphorylation of Tiam1 in Swiss 3T3 fibroblasts via activation of protein kinase C. J. Biol. Chem. 272: 33105-33110.
34. Levine, L., H. B. Gjika, and H. Van Vunakis. 1989. Antibodies and radioimmunoassays for phosphoserine, phosphothreonine and phosphotyrosine. Serologic specificities and levels of the phosphoamino acids in cytoplasmic fractions of rat tissues. J. Immunol. Methods 124: 239-249.
35. 2. Clin. Chim. Acta 179: 177-181.
36. Deregibus, M. C., S. Buttiglieri, S. Russo, B. Bussolati, and G. Camussi. 2003. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J. Biol. Chem. 278: 18008-18014.
37. Banerjee, S., K. Narayanan, T. Mizutani, and S. Makino. 2002. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J. Virol. 76: 5937-5948.
38. Skoberne, M., A. S. Beignon, and N. Bhardwaj. 2004. Danger signals: a time and space continuum. Trends Mol. Med. 10: 251-257.
39. Henneke, P., and D. T. Golenbock. 2001. TTRAP: how Toll receptors fraternize. Nat. Immunol. 2: 828-830.
40. Loiarro, M., C. Sette, G. Gallo, A. Ciacci, N. Fanto, D. Mastroianni, P. Carminati, and V. Ruggiero. 2005. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-κB. J. Biol. Chem. 280: 15809-15814.
41. Laroux, F. S., X. Romero, L. Wetzler, P. Engel, and C. Terhorst. 2005. Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. J. Immunol. 175: 5596-5600.
42. Brown, G. E., M. Q. Stewart, S. A. Bissonnette, A. E. Elia, E. Wilker, and M. B. Yaffe. 2004. Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase. J. Biol. Chem. 279: 27059-27068.
43. Brandes, R. P., and J. Kreuzer. 2005. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res. 65: 16-27.
44. Abraham, E., J. Arcaroli, A. Carmody, H. Wang, and K. J. Tracey. 2000. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165: 2950-2954.
45. Erlandsson Harris, H., and U. Andersson. 2004. Mini-review: the nuclear protein HMGB1 as a proinflammatory mediator. Eur. J. Immunol. 34: 1503-1512.
46. Andersson, U., H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom, H. Erlandsson-Harris, A. Janson, R. Kokkola, M. Zhang, H. Yang, and K. J. Tracey. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565-570.
47. Czura, C. J., and K. J. Tracey. 2003. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit. Care Med. 31: S46-50.
48. Wang, H., H. Yang, C. J. Czura, A. E. Sama, and K. J. Tracey. 2001. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164: 1768-1773.
49. Ombrellino, M., H. Wang, M. S. Ajemian, A. Talhouk, L. A. Scher, S. G. Friedman, and K. J. Tracey. 1999. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 354: 1446-1447.
50. Bianchi, M. E., and A. Manfredi. 2004. Chromatin and cell death. Biochim. Biophys. Acta 1677: 181-186.
51. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
52. Huttunen, H. J., C. Fages, and H. Rauvala. 1999. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κ require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274: 19919-19924.
53. Huttunen, H. J., C. Fages, J. Kuja-Panula, A. J. Ridley, and H. Rauvala. 2002. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res. 62: 4805-4811.
54. 2 microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J. Clin. Invest. 98: 1088-1094.
55. Taniguchi, N., K. Kawahara, K. Yone, T. Hashiguchi, M. Yamakuchi, M. Goto, K. Inoue, S. Yamada, K. Ijiri, S. Matsunaga, et al. 2003. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48: 971-981.
56. Treutiger, C. J., G. E. Muffins, A. S. Johansson, A. Rouhiainen, H. M. Rauvala, H. Erlandsson-Hams, U. Andersson, H. Yang, K. J. Tracey, J. Andersson, and J. E. Palmblad. 2003. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 254: 375-385.
57. Park, J. S., F. Gamboni-Robertson, Q. He, D. Svetkauskaite, J. Y. Kim, D. Strassheim, J. W. Sohn, S. Yamada, I. Maruyama, A. Banerjee, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. 290: C917-C924.
58. Park, H. S., H. Y. Jung, E. Y. Park, J. Kim, W. J. Lee, and Y. S. Bae. 2004. Cutting edge: direct interaction of TLR4 with NADPH oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173: 3589-3593.
59. phox phosphorylation in human neutrophils. J. Immunol. 165: 5238-5244.
60. Curnutte, J. T., R. W. Erickson, J. Ding, and J. A. Badwey. 1994. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with a phorbol ester. J. Biol. Chem. 269: 10813-10819.
61. phox using tryptophan fluorescence spectroscopy. J. Biol. Chem. 272: 29502-29510.
62. phox during activation studied through its intrinsic fluorescence. Biochim. Biophys. Acta 1387: 406-414.